Device is described as the smallest and thinnest fully implantable SCS system with lithium battery, two leads, and full-body MRI access
Inceptiv senses biological signals along the spinal cord and adjusts stimulation in real time for personalized pain relief
Medtronic receives FDA approval for Inceptiv, the world's first closed-loop spinal cord stimulator
Medtronic's Newest Innovation: Inceptiv, the Game-Changing Closed-Loop Spinal Cord Stimulator for Chronic Pain Relief
Medtronic, a global leader in healthcare technology, has recently received FDA approval for its latest innovation in spinal cord stimulation (SCS) technology - the Inceptiv closed-loop rechargeable SCS system. This marks the first time Medtronic offers a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time, providing personalized pain relief for patients dealing with chronic pain.
The Inceptiv system is designed to keep therapy in harmony with daily life movements. Traditional SCS methods deliver constant electrical impulses, which may result in uncomfortable stimulation during certain activities like laughing, bending or sneezing. However, the closed-loop feature of Inceptiv enables it to sense the body's response to stimulation 50 times per second and adjust accordingly.
The device is also described as the world's smallest and thinnest fully implantable SCS system. It features a lithium battery that can be recharged through the skin, two leads with electrodes for reading signals and delivering electrical pulses, and full-body MRI access with no power or impedance restrictions.
Medtronic's Vice President and General Manager of Pain Interventions within the Neuromodulation business, David Carr, expressed his excitement about this new era for SCS technology:
Medtronic's new spinal-cord implant, called Inceptiv, has received FDA approval for relieving chronic pain.
Inceptiv can read signals from nerve fibers and automatically adjust the intensity of stimulation.
Inceptiv is designed to work like ‘adaptive cruise control’, modifying the electrical pulse according to the body’s feedback.
The device contains a lithium battery that can be recharged through the skin and two leads with electrodes for reading signals and delivering electrical pulses.
Inceptiv is described as ‘the world’s smallest and thinnest fully implantable spinal-cord stimulator''
Some patients report feeling a ‘zap or a zing down their back’ with implants that deliver constant stimulation.
The approval comes at a challenging period for Medtronic, whose share price has fallen about 40 percent from its peak in 2021.
Medtronic's Inceptiv closed-loop rechargeable spinal cord stimulator has received FDA approval for the treatment of chronic pain.
Inceptiv is the first Medtronic SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time.
Inceptiv offers multiple types of waveforms, including Medtronic’s proprietary DTM SCS therapy which demonstrated an 84% responder rate at 12 months in a large, multicenter randomized controlled trial.
Medtronic's Inceptiv closed-loop rechargeable spinal cord stimulator system has received FDA approval.
Inceptiv is the first SCS device from Medtronic to offer a closed-loop feature.
Inceptiv utilizes a closed-loop capability with ECAPs based on decades of Medtronic research.
Inceptiv enables full-body MRI access with no power or impedance restrictions, making it the only FDA-approved closed-loop SCS offering full-body 3T MRI access.
